Quick Answer
CATALYST PHARMACEUTICALS, INC. reported Total Assets of $1.10 billion for fiscal year 2025.
CATALYST PHARMACEUTICALS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.10B | +29.7% |
| 2024 | $851.41M | +81.1% |
| 2023 | $470.11M | +25.2% |
| 2022 | $375.63M | +58.0% |
| 2021 | $237.79M | +23.6% |
| 2020 | $192.35M | +71.2% |
| 2019 | $112.38M | +85.9% |
| 2018 | $60.45M | -29.2% |
| 2017 | $85.39M | +104.7% |
| 2016 | $41.71M | -30.6% |
| 2015 | $60.10M | +36.9% |
| 2014 | $43.91M | +73.1% |
| 2013 | $25.37M | +51.1% |
| 2012 | $16.79M | +168.7% |
| 2011 | $6.25M | +7.2% |
| 2010 | $5.83M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.05B | +36.2% | +8.2% |
| June 30, 2025 | $971.91M | +37.6% | +6.9% |
| March 31, 2025 | $908.87M | +40.5% | +6.7% |
| December 31, 2024 | $851.41M | +81.1% | +10.3% |
| September 30, 2024 | $772.01M | +86.8% | +9.3% |
| June 30, 2024 | $706.36M | +59.1% | +9.2% |
| March 31, 2024 | $646.68M | +58.8% | +37.6% |
| December 31, 2023 | $470.11M | +25.2% | +13.8% |
- CATALYST PHARMACEUTICALS, INC. showed an increase of +29.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, CATALYST PHARMACEUTICALS, INC.’s total assets has grown by 18831.3% (from $5.83 million to $1.10 billion).
- The most recent figure is from CATALYST PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: